Not Found
On Demand

Controversies in Thyroidology: Controversies Regarding the Role of Molecular Testing in Thyroid Nodules: A Case Based Discussion


Duration:
1 Hour 30 Minutes


Tag: Live


Description

Our ninth of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office. 


Program Details

This course includes a live Q&A session with faculty. Join the August 10, 2020 1:00 PM ET broadcast to be a part of the live Q&A session or post August 10 watch this program on-demand and receive 1.5 credits until August 31, 2021. View the Accreditation Statement/Credit tab for details.

 

Controversies in Thyroidology: Controversies Regarding the Role of Molecular Testing in Thyroid Nodules: A Case Based Discussion  

 

Moderators: Whitney S. Goldner, MD and Kepal Patel, MD

 

Faculty: Miriam Lango, MD, Matthew D. Ringel, MD and Tracy S. Wang, MD, MPH, FACS

 

     Learning Objectives:

  • Understand the advantages and pitfalls of molecular testing for thyroid nodules

  • Become familiar with the role of molecular testing in biopsy proven thyroid cancer

  • Know how molecular testing can be used to guide extent of treatment, surgical and non-surgical

  • Become aware of the role of molecular testing to guide active surveillance in thyroid cancer


Learn more...

Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/


Who Should Attend

American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).

Credits

Accreditation Statement/Credit

Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.

 

Disclosure Statement

Dr. Whitney Goldner receives research/grant support from Roche. All other faculty (Drs. Miriam Lango, Kepal Patel, Matthew Ringel and Tracy Wang) did not disclose any relevant financial disclosures and do not intend to reference off-label/unapproved uses of products or devices. To view disclosure information for the full planning committee, click here

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Colorado School of Medicine designates this enduring material for a maximum of  1.50 AMA PRA Category 1 CreditTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC).  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation

 

 

Completion of Learning Assessment by Participant

Credit Disseminated

(CME Certificates sent to Attendee Email provided and/or ABIM MOC Data Uploaded and/or ABOHNS MOC Data Uploaded)

May 29, 2020 – August 31, 2020 

September 15, 2020

September 1, 2020 – November 30, 2020

December 15, 2020

December 1, 2020 – February 28, 2021

March 15, 2021

March 1, 2021 – May 31, 2021

June 15, 2021

June 1, 2021 – August 31, 2021

September 15, 2021




Faculty

Matthew Ringel's Profile

Matthew Ringel Related seminars and products: 2

THE OHIO STATE UNIVERSITY


Matthew Ringel, MD is a professor and director of the Division of Endocrinology, Metabolism and Diabetes at The Ohio State University, where he also serves as co-leader of the Cancer Biology Program at the OSUCCC – James and holds the Ralph W. Kurtz Chair in Hormonology. Dr. Ringel focuses his research on molecular mechanisms involved in thyroid cancer invasion and metastasis, with an active interest in new drug testing for thyroid cancer therapy. Among his current research activities is serving as principal investigator (PI) for a National Cancer Institute (NCI) grant-funded study of the “Role of P21-Activated Kinases in Thyroid Cancer.” Dr. Ringel and colleagues have identified a potentially important pathway (p21 activated kinase, or PAK) downstream of the BRAF gene that may be involved in the progression of papillary thyroid cancer, which is incurable when metastatic and progressive. His team hopes to determine the relevance of the PAK pathway in vivo, clarify the mechanism by which it is activated and test novel compounds that block PAK activation with a goal of determining whether PAK is a viable therapeutic target. Dr. Ringel has also served as PI for a multimillion-dollar, NCI-funded program project grant (PPG) to study “Genetic and Signaling Pathways in Epithelial Thyroid Cancer” and for an NCI-funded Specialized Program of Research Excellence (SPORE) grant to help improve the lives of patients with thyroid cancer. Both grants entailed several interactive projects and multiple investigators at Ohio State and other academic institutions.


Tracy Wang's Profile

Tracy Wang Related seminars and products: 2

Medical College of Wisconsin


Tracy S. Wang, MD, MPH, FACS is currently Professor of Surgery, Vice-Chair of Strategic and Professional Development, and Chief of the Section of Endocrine Surgery in the Department of Surgery at the Medical College of Wisconsin (Milwaukee, WI). She completed her residency in General Surgery at Long Island Jewish Medical Center and fellowship in Endocrine Surgery at Yale University. Her clinical practice is focused on the surgical endocrine disease of the thyroid, parathyroid, and adrenal glands, including inherited endocrine syndromes. Dr. Wang has published >150 peer-reviewed manuscripts and book chapters. Dr. Wang is the Program Leader for the Endocrine Cancer program at the Froedtert Hospital/Medical College of Wisconsin Cancer Center and Program Director of the MCW Comprehensive Endocrine Surgery Fellowship. She is currently Councilor-at-Large for the Society of Surgical Oncology, President-Elect of the Society of Asian Academic Surgeons, and Treasurer of the American Association of Endocrine Surgeons. She also serves on the Editorial Boards of Clinical Thyroidology, World Journal of Surgery, Journal of Surgical Research, and American Journal of Surgery.


Miriam Lango's Profile

Miriam Lango Related seminars and products: 2

Fox Chase Cancer Center/ Temple University Health System


Fox Chase Cancer Center/Temple University Health System, The Woodlands, TX, USA


Whitney S. Goldner, MD's Profile

Whitney S. Goldner, MD Related seminars and products: 4

Dr. Whitney Goldner

University of Nebraska Medical Center


Whitney Goldner, MD is an Endocrinologist at the University of Nebraska Medical Center, Omaha, NE. She is an Associate Professor of Medicine in the Division of Diabetes, Endocrinology, and Metabolism, Dept of Internal Medicine. She is the PI of ICaRe2, which is a bioinformatics registry and biospecimen bank at UNMC for thyroid nodules and thyroid cancer. She specializes in thyroid disease, thyroid nodules, and thyroid cancer as well as neuroendocrine tumors and other Endocrine disorders. She is the Endocrinology Fellowship Program director and runs the thyroid ultrasound and biopsy clinics.


Kepal Patel's Profile

Kepal Patel Related seminars and products: 4


Kepal N. Patel, MD is the Chief of the Division of Endocrine Surgery and an Associate Professor of Surgery, Otolaryngology and Biochemistry at NYU Langone Medical Center. He is the Director of the Thyroid Interdisciplinary Program and has particular expertise in the multidisciplinary treatment of Thyroid and Parathyroid disease along with other head and neck tumors. He also leads the translational research program for the Division of Endocrine Surgery. Dr. Patel has been studying the molecular pathogenesis of thyroid carcinoma by focusing on the changes in intracellular pathways that lead to the progression of thyroid cancer. His research interests also include studying the relationship of autoimmune thyroiditis to thyroid cancer at the genomic level.
He earned his M.D. from UMDNJ-Robert Wood Johnson Medical School and completed his Oncologic Head and Neck Surgery training at Memorial Sloan-Kettering Cancer Center. Dr. Patel’s work has been recognized by numerous awards from prestigious societies such as the American Society of Clinical Oncology, American Head and Neck Society, American Association of Endocrine Surgeons, and the American Thyroid Association. He currently serves in multiple leadership roles both locally and nationally and is a reviewer and on the editorial board of several journals.


Accreditation Statement/Credit

Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.

 

Disclosure Statement

Dr. Whitney Goldner receives research/grant support from Roche. All other faculty (Drs. Miriam Lango, Kepal Patel, Matthew Ringel and Tracy Wang) did not disclose any relevant financial disclosures and do not intend to reference off-label/unapproved uses of products or devices. To view disclosure information for the full planning committee, click here

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Colorado School of Medicine designates this enduring material for a maximum of  1.50 AMA PRA Category 1 CreditTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC).  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation

 

 

Completion of Learning Assessment by Participant

Credit Disseminated

(CME Certificates sent to Attendee Email provided and/or ABIM MOC Data Uploaded and/or ABOHNS MOC Data Uploaded)

May 29, 2020 – August 31, 2020 

September 15, 2020

September 1, 2020 – November 30, 2020

December 15, 2020

December 1, 2020 – February 28, 2021

March 15, 2021

March 1, 2021 – May 31, 2021

June 15, 2021

June 1, 2021 – August 31, 2021

September 15, 2021

Please wait ...

Back to Top